Rhizen Pharma’s partnered asset Umbralisib gets US FDA accelerated nod for relapsed or refractory marginal zone lymphoma, follicular lymphoma

Read more

Bain Capital, Cinven to acquire Lonza Specialty Ingredients for $4.7 billion

Read more

881 ongoing overcharging cases worth Rs 8184.19 cr under DPCO: D V Sadananda Gowda

Read more

SMS Life Sciences India gets DSIR recognition for Hyderabad R&D unit

Read more

Indian pharma market expected to grow to $130 bn by 2030: Gowda

Read more

US FDA makes five observations after Alembic Pharma facility inspection

Read more

Clinical Data Standards in the era of AI, ML and digital transformation

Read more

Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData

Read more

India set to meet world’s 70 per cent COVID-19 vaccine needs: Amit Shah

Read more

UK says COVID-19 booster and annual vaccinations very probable

Read more